Gout Discovery at Duke University Could Lead to New Treatment

Article

A new treatment for treating Gout can normalize levels of uric acid in the blood within hours in patients who have failed to respond to any other treatments.

Thanks to a study from Duke University, a new way of treating gout is being explored that can normalize levels of uric acid in the blood within hours in patients who have failed to respond to any other treatments. The experimental new drug being tested targets and attacks excess uric acid, the root cause of Gout, and converts it into another chemical that is released through the urine. Researchers have even found that the drug reduces the size of crystalline deposits of uric acid, a common occurrence in Gout patients.

Related Videos
Connective Tissue Disease Brings Dermatology & Rheumatology Together
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
© 2024 MJH Life Sciences

All rights reserved.